不同剂量倍他乐克对于扩张型心肌病心力衰竭的治疗(2)
 |
| 第1页 |
参见附件(3077KB，3页)。
[9] Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction in the geberal population. Eur Heart J, 1999, 20: 447-455.
[10] McDonagh TA， Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet, 1997, 350: 829-833.
[11] Cowie MR, Wood DA, Coats AJ, et al. Survial of patients with a new diagnosis of heart failure: a population based study.Heart, 2000, 83: 505-510.
[12] Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intem Med, 1999, 159: 29-34.
[13] The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med, 1992, 327: 685-691.
[14] Kober L, Torp-Pedersen C, Carlsen JE, et al. for the Trandolapril Cardiac Evaluation (TRACE) Study Group. Effects on mortality by trandolapril after myocardial infarction. N Engl J Med, 2005, 333: 1670-1676.
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
您现在查看是摘要介绍页，详见PDF附件(3077KB，3页)。